Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kamux ends all cooperation with Teboil

Kamux Corporation     Press Release    February 26, 2022 at 19:30 (EET) Kamux ends all cooperation with Teboil Due to the situation in Ukraine, Kamux has decided to immediately end all cooperation with Teboil. Teboil is a subsidiary of the Russian oil company Lukoil. We condemn Russia's invasion of Ukraine, and ending cooperation is a question of values and responsibility. Kamux Corporation For more information: Juha Kalliokoski, CEO, tel. +358 40 185 8633 Kamux communications, Satu Otala, tel. +358 40 164 5036 ir@kamux.fi Kamux Corporation is a retail chain

Ukrainian refugees with their pets should be allowed into EU Member States without paperwork delay, says EU Commission in ‘precedent setting’ compassionate decision

BRUSSELS (26 Feb. 2022) – Animal charity Humane Society International/Europe applauds the European Commission for advising all EU Member States to relax veterinary paperwork requirements for the dogs, cats and other companion animals travelling with refugees seeking safe passage in EU Member States. In a communication shared with HSI and other members of the EU Animal Welfare Platform, Bernard Van Goethem, Director of Crisis Preparedness in food, animals and plants at DG SANTE wrote to the Chief Veterinary Officers and Permanent Representations of all Member States, saying: “In view

Hansa Biopharma announces positive early access decision by French Haute Autorité de Santé to use Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients

· Decision to use commercially supplied Idefirix® (imlifidase) in approved indication by the European Medicines Agency (EMA)1,2              · Decision provides highly sensitized patients in France with the opportunity to immediately receive Idefirix® as desensitization treatment · Commercial launch activities for Idefirix® in Europe continue to progress Lund, Sweden, February 25, 2022. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announces that its first-in-class treatment Idefirix® (imlifidase)

Josemaria Publishes 2021 Annual Filings

VANCOUVER, BC, February 25, 2022 /CNW/ - Josemaria Resources Inc. (TSX: JOSE) (OMX: JOSE) (OTCQB: JOSMF) (“Josemaria” or the “Company”) announces that the 2021 Annual Filings Document is available for download from the Company’s website: https://www.josemariaresources.com/investors/financial-reports/financial-statements/.   This is information that the Company is obliged to make public pursuant to the Swedish Markets Act.  The information was submitted for publication, through the agency of the contact person set out below, on February 25, 2022 17:30 EST.   On behalf of

Josemaria Reports 2021 Year-End Results

VANCOUVER, BC, February 25, 2022 /CNW/: Josemaria Resources Inc. (TSX: JOSE) (OMX: JOSE) (OTCQB: JOSMF) (“Josemaria Resources”, the “Company” or “Josemaria”), is pleased to announce its results for the year ended December 31, 2021. Adam Lundin, Josemaria Resources’ Chief Executive Officer, comments: “As we continue to advance the Josemaria Project via Basic Engineering, a multi-faceted 65,000-metre drill program which commenced in Q4 2021, and active engagement with federal and San Juan provincial authorities in Argentina regarding ESIA approval and commercial and fiscal terms applicable

Correction: ODI Pharma AB: Publication of half-year report 2021

Correction: ODI Pharma hereby discloses a revised half-year report for the period July – December 2021. In the previous report, the cost of goods sold was incorrect for the period and first six months, thereby impacting the operating profit and below in profit and loss. Further, the finished goods and goods for resale in the balance sheet has been adjusted. Also, other equity including result for the period is adjusted in the balance sheet. Finally, change in inventories and ongoing works is adjusted in the cash flow statement, thereby impacting the cash flow for the period. The revised half-

Nordea Bank Abp: Repurchase of own shares on 25.02.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares25.02.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 25.02.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 758,755 9.83 7,457,349.27XHEL 625,556 9.91 6,202,200.07CEUX 668,446 9.86 6,590,466.55AQEU 50,712 9.87

Notice to the Annual General Meeting of Konecranes Plc

KONECRANES PLC STOCK EXCHANGE RELEASE February 25, 2022 at 8:30 pm EET Notice to the Annual General Meeting of Konecranes Plc Notice is given to the shareholders of Konecranes Plc (“Konecranes” or the “Company”) to the Annual General Meeting to be held on Wednesday 30 March 2022 at 10.00 am at the Company’s address at Keilaranta 13 A, FI-02150 Espoo, Finland. The shareholders of the Company and their proxy representatives may participate in the meeting and exercise shareholder rights only through voting in advance as well as by making counterproposals in advance and presenting

Correction: TOMRA: Key information relating to the proposed share split in TOMRA Systems ASA

The Board of Directors of TOMRA Systems ASA has decided on 22 February 2022 to propose at the upcoming Annual General Meeting a share split of 1:2. Announcement date: 23 February 2022 Split ratio: one (1) old share will give two (2) new shares Last day including right to have one share traded into two: 25 May 2022 Ex-date: 27 May 2022 Record date: 30 May 2022 Date of approval: 28 April 2022 This information is published in accordance with the requirements of the Continuing Obligations. This information is subject to the disclosure requirements pursuant to section 5 -

SRV Group Plc: Repurchase of own shares on 25 February 2022

SRV GROUP PLC     STOCK EXCHANGE RELEASE     25 FEBRUARY 2022      18:45 EET   SRV Group Plc repurchase of own shares on 25.02.2022     +------------------------+----------+|SRV Group Plc |  |+------------------------+----------+|In the Nasdaq Helsinki |  |+------------------------+----------+|Date |25.02.2022|+------------------------+----------+|Exchange transaction |BUY |+------------------------+----------+|Share trading code |SRV1V |+------------------------+----------+|Amount, shares

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 25.02.2022

United Bankers Plc NOTIFICATION 25.02.2022 at 18:30 UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 25.02.2022 Date 25.02.2022Exchange transaction BuyShare class UNITEDAmount 323Average price/share 13.6000 EURHighest price/share 13.6000 EURLowest price/share 13.6000 EURTotal price 4,392.80 EUR The shares held by United Bankers Plc on 25.02.2022: UNITED 61,688 On behalf of United Bankers Plc  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Janne Tiihonen For

Update on the recruitment process of Solteq Plc’s CEO

Stock Exchange Bulletin February 25, 2022 at 6:30 p.m. The recruitment process of Solteq Plc’s new CEO has been updated, and the Board of Directors aims to appoint the new CEO by the end of March 2022. Previously, in the stock exchange bulletin issued on January 14, 2022, the company estimated to make an announcement of a new CEO by the end of February 2022. The company's Interim CEO Kari Lehtosalo will continue in his position until further notice. Solteq PlcBOARD OF DIRECTORS Distribution: NASDAQ OMX Helsinki Key media www.solteq.com Further information:  Chairman of

Karnov Group progresses in the contemplated acquisition of carved out legal information-based businesses of both Thomson Reuters in Spain and Wolters Kluwer in Spain and France

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE IN ACCORDANCE WITH APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION TO BUY ANY SECURITIES IN THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION. On 9 December 2021, Karnov Group AB (publ) (“Karnov” or the “Company”) announced its submission of a binding offer to acquire

Atea ASA - share buyback

Oslo, 25 February On 25 February 2022, Atea ASA has purchased a total of 50,000 own shares at the Oslo Stock Exchange at an average price of NOK 132.34 per share. Following the completion of the above transactions, Atea ASA owns a total of 447,511 own shares, corresponding to 0.40% of Atea ASA's share capital. Additional information on the buyback program: Date on which the buyback program was announced: 11 February 2022 The duration of the buyback program: 14 February 2022 to 31 March 2022, or until the maximum number of shares has been repurchased. Size of the buyback

Notice of JM AB’s Annual General Meeting on March 31, 2022

JM AB (publ) is announcing via this press release the notice of Annual General Meeting on March 31, 2022. The notice will be published on JM’s website on Wednesday, March 2, 2022. The notice will also be published in Post- och Inrikes Tidningar (Swedish Official Gazette) on the same day, and information that the notice has been published will be announced in the newspaper Svenska Dagbladet.NOTICE OF ANNUAL GENERAL MEETING OF JM AB (PUBL) ON MARCH 31, 2022 Shareholders in JM AB (publ) (CIN 556045-2103, domiciled in Stockholm) are invited to attend the Annual General Meeting on Thursday,

Report for the period 1 Jan – 31 Dec 2021

October – December 2021 · Net sales amounted to SEK 3.02 m (2.99) · Net operating income was SEK 406,000 (207,000) · The operating profit was SEK 44.80 m (3.47) · The profit for the period was SEK 42.71 m (-8.28) · Earnings per share before and after dilution were SEK 85.41 (-16.55) 1 January– 31 December 2021 · Net sales amounted to SEK 11.28 m (11.25) · Net operating income was SEK -247.000 (-2,67 m) · The operating profit was SEK 11.96 m (-14.58) · The profit for the period was SEK 5.35 m (-61.16) · Earnings per share before and after dilution were

NOTICE TO THE EXTRAORDINARY GENERAL MEETING

The shareholders of Modern Times Group MTG AB (publ) are hereby given notice to the Extraordinary General Meeting on 22 March 2022. In order for the Extraordinary General Meeting to be conducted in a manner that limits the risk of spreading Covid-19, the Board has decided that the Extraordinary General Meeting should be conducted only through postal voting in accordance with temporary legislation. It will not be possible for shareholders to attend the Extraordinary General Meeting in person or by way of a proxy holder. Information on the resolutions adopted by the Extraordinary General

#22-65 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

SimCorp A/S – Announcement of Managers’ Transactions

Announcement and public disclosure of transactions in SimCorp A/S shares by persons discharging managerial responsibilities and persons closely associated with them1. Details of the person with managerial responsibilities/person closely associateda) Name Joan Binstock2. Reason for the notificationa) Position/status Board member, member of the Audit and Risk Committeeb) Initial notification/Amendment Initial notification3. Details of the issuer, emission allowance market

Notice of Extraordinary General Meeting of Shareholders in Alligo AB (publ) on 23 March 2022

The shareholders in Alligo AB (publ), corporate registration number 559072-1352 (”Alligo” or the ”Company”), are hereby convened to an Extraordinary General Meeting of Shareholders at 10:00 on Wednesday, 23 March 2022 at Kapitel 8, Klarabergsviadukten 90, Stockholm. Registration for the meeting will commence at 09:30.NOTICE OF PARTICIPATION Shareholders who wish to participate in the Extraordinary General Meeting must: · be recorded in the shareholders’ register maintained by Euroclear Sweden AB on Tuesday, 15 March 2022, · file notice of their intention to participate with the

Holding(s) in Company

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS(to besent to the relevantissuer and tothe FCA in MicrosoftWord format ifpossible)[i] 1a. Identity of the EnQuest PLCissuer or theunderlying issuer ofexisting sharesto which votingrights areattached[ii]:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An acquisition or

Alligo proposes distribution and listing of Momentum Group on Nasdaq Stockholm

The Board of Directors of Alligo AB (publ) (“Alligo” or the “Company”) has today decided to propose that the shareholders of Alligo at Extraordinary General Meeting on 23 March 2022 resolve to distribute all of Alligo’s shares in the subsidiary Momentum Group AB (publ) (“Momentum Group”) to the shareholders of Alligo (the "Distribution"). Furthermore, Nasdaq Stockholm has made the assessment that Momentum Group meets the applicable listing requirements on Nasdaq Stockholm and will approve an application for admission to trading of Momentum Group’s Class B shares subject to that certain

Publication of a Prospectus

Regulatory Announcement       Royal Bank of Canada February 25, 2022   Publication of Prospectus   Not for release, publication or distribution, directly or indirectly, in or into the United States.   The following prospectus has been approved by the Financial Conduct Authority and, along with the documents incorporated by reference therein, is available for viewing:   3rd Supplementary Prospectus dated February 25, 2022 relating to the Programme for the €60,000,000,000 Global Covered Bond Programme of Royal Bank of Canada, unconditionally and

NOTICE OF ANNUAL GENERAL MEETING IN NAXS AB (publ)

Not for release, publication or distribution, directly or indirectly, in or into the United States, Hong Kong, Canada, Japan or Australia, or any other jurisdiction in which the distribution or release would be unlawful. N.B. The English text is an in-house translation. In the event of any discrepancies between the text in this document and the Swedish document, the latter shall prevail. The shareholders of NAXS AB (publ), reg. no. 556712-2972, with its registered office in Stockholm (the “Company” or “NAXS”), are hereby invited to the annual general meeting (the “Meeting”) on

There are no items matching the current filter
There are no more items matching the current filter
Back to top